BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22527638)

  • 1. Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro.
    Govindan S; Sarkey J; Ji X; Sundaresan NR; Gupta MP; de Tombe PP; Sadayappan S
    J Muscle Res Cell Motil; 2012 May; 33(1):17-30. PubMed ID: 22527638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial infarction-induced N-terminal fragment of cardiac myosin-binding protein C (cMyBP-C) impairs myofilament function in human myocardium.
    Witayavanitkul N; Ait Mou Y; Kuster DW; Khairallah RJ; Sarkey J; Govindan S; Chen X; Ge Y; Rajan S; Wieczorek DF; Irving T; Westfall MV; de Tombe PP; Sadayappan S
    J Biol Chem; 2014 Mar; 289(13):8818-27. PubMed ID: 24509847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino terminus of cardiac myosin binding protein-C regulates cardiac contractility.
    Lynch TL; Kumar M; McNamara JW; Kuster DWD; Sivaguru M; Singh RR; Previs MJ; Lee KH; Kuffel G; Zilliox MJ; Lin BL; Ma W; Gibson AM; Blaxall BC; Nieman ML; Lorenz JN; Leichter DM; Leary OP; Janssen PML; de Tombe PP; Gilbert RJ; Craig R; Irving T; Warshaw DM; Sadayappan S
    J Mol Cell Cardiol; 2021 Jul; 156():33-44. PubMed ID: 33781820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cardiac myosin-binding protein C restricts actin structural dynamics in a cooperative and phosphorylation-sensitive manner.
    Bunch TA; Kanassatega RS; Lepak VC; Colson BA
    J Biol Chem; 2019 Nov; 294(44):16228-16240. PubMed ID: 31519753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.
    Kuster DW; Govindan S; Springer TI; Martin JL; Finley NL; Sadayappan S
    J Biol Chem; 2015 Feb; 290(9):5855-67. PubMed ID: 25583989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal cardiac contraction in mice lacking the proline-alanine rich region and C1 domain of cardiac myosin binding protein C.
    van Dijk SJ; Witt CC; Harris SP
    J Mol Cell Cardiol; 2015 Nov; 88():124-32. PubMed ID: 26455481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel "Cut and Paste" Method for In Situ Replacement of cMyBP-C Reveals a New Role for cMyBP-C in the Regulation of Contractile Oscillations.
    Napierski NC; Granger K; Langlais PR; Moran HR; Strom J; Touma K; Harris SP
    Circ Res; 2020 Mar; 126(6):737-749. PubMed ID: 32078438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point mutations in the tri-helix bundle of the M-domain of cardiac myosin binding protein-C influence systolic duration and delay cardiac relaxation.
    van Dijk SJ; Kooiker KB; Napierski NC; Touma KD; Mazzalupo S; Harris SP
    J Mol Cell Cardiol; 2018 Jun; 119():116-124. PubMed ID: 29729251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac myosin binding protein-C phosphorylation regulates the super-relaxed state of myosin.
    McNamara JW; Singh RR; Sadayappan S
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11731-11736. PubMed ID: 31142654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac myosin-binding protein C interaction with actin is inhibited by compounds identified in a high-throughput fluorescence lifetime screen.
    Bunch TA; Guhathakurta P; Lepak VC; Thompson AR; Kanassatega RS; Wilson A; Thomas DD; Colson BA
    J Biol Chem; 2021 Jul; 297(1):100840. PubMed ID: 34052227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction.
    Govindan S; McElligott A; Muthusamy S; Nair N; Barefield D; Martin JL; Gongora E; Greis KD; Luther PK; Winegrad S; Henderson KK; Sadayappan S
    J Mol Cell Cardiol; 2012 Jan; 52(1):154-64. PubMed ID: 21971072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Terminal Fragment of Cardiac Myosin Binding Protein C Modulates Cooperative Mechanisms of Thin Filament Activation in Atria and Ventricles.
    Kochurova AM; Beldiia EA; Nefedova VV; Ryabkova NS; Yampolskaya DS; Matyushenko AM; Bershitsky SY; Kopylova GV; Shchepkin DV
    Biochemistry (Mosc); 2024 Jan; 89(1):116-129. PubMed ID: 38467549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Terminal Fragment of Cardiac Myosin Binding Protein-C Increases the Duration of Actin-Myosin Interaction.
    Nabiev SR; Kochurova AM; Nikitina LV; Beldiia EA; Matyushenko AM; Yampolskaya DS; Bershitsky SY; Kopylova GV; Shchepkin DV
    Bull Exp Biol Med; 2024 Jan; 176(3):324-327. PubMed ID: 38336971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Acute Effects of Leptin on the Contractility of Isolated Rat Atrial and Ventricular Cardiomyocytes.
    Khokhlova A; Myachina T; Butova X; Kochurova A; Polyakova E; Galagudza M; Solovyova O; Kopylova G; Shchepkin D
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanosurfer assay dissects β-cardiac myosin and cardiac myosin-binding protein C interactions.
    Touma AM; Tang W; Rasicci DV; Vang D; Rai A; Previs SB; Warshaw DM; Yengo CM; Sivaramakrishnan S
    Biophys J; 2022 Jun; 121(12):2449-2460. PubMed ID: 35591788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the critical residues responsible for cardiac myosin binding protein C's interactions.
    Bhuiyan MS; Gulick J; Osinska H; Gupta M; Robbins J
    J Mol Cell Cardiol; 2012 Dec; 53(6):838-47. PubMed ID: 22982234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
    De Lange WJ; Grimes AC; Hegge LF; Spring AM; Brost TM; Ralphe JC
    J Gen Physiol; 2013 Sep; 142(3):241-55. PubMed ID: 23980194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique single molecule binding of cardiac myosin binding protein-C to actin and phosphorylation-dependent inhibition of actomyosin motility requires 17 amino acids of the motif domain.
    Weith A; Sadayappan S; Gulick J; Previs MJ; Vanburen P; Robbins J; Warshaw DM
    J Mol Cell Cardiol; 2012 Jan; 52(1):219-27. PubMed ID: 21978630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy.
    Kuster DWD; Lynch TL; Barefield DY; Sivaguru M; Kuffel G; Zilliox MJ; Lee KH; Craig R; Namakkal-Soorappan R; Sadayappan S
    Cardiovasc Res; 2019 Dec; 115(14):1986-1997. PubMed ID: 31050699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.